Literature DB >> 10537178

Type 3 iodothyronine deiodinase is selectively expressed in areas related to sexual differentiation in the newborn rat brain.

M J Escámez1, A Guadaño-Ferraz, A Cuadrado, J Bernal.   

Abstract

Thyroid hormone (T4 and T3) concentrations in target tissues are greatly influenced by the activity of iodothyronine deiodinases. Type 1 and 2 deiodinases generate T3 from T4, while deiodinase type 3 (D3) transforms T4 and T3 to inactive metabolites. Coordination of the expression and activity of these enzymes is postulated to play an important role in physiology and development, making it possible that individual cells and tissues regulate the concentrations of the active hormone according to specific needs. We have analyzed the expression of D3 in the neonatal rat brain by in situ hybridization using a specific 35S-labelled riboprobe. At postnatal day 0 D3 transcripts were unexpectedly found to be selectively expressed in areas involved in sexual differentiation of the brain such as the bed nucleus of the stria terminalis and preoptic nuclei. Expression in these areas was transient and was no longer observed at postnatal day 10. These observations suggest that D3 expression is linked to the early mechanism determining sexual function and behavior.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537178     DOI: 10.1210/endo.140.11.7244

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Thyroid hormone regulates the obesity gene tub.

Authors:  N P Koritschoner; M Alvarez-Dolado; S M Kurz; M F Heikenwälder; C Hacker; F Vogel; A Muñoz; M Zenke
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

Review 2.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

3.  Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems.

Authors:  J P Stohn; M E Martinez; M Zafer; D López-Espíndola; L M Keyes; A Hernandez
Journal:  Genes Brain Behav       Date:  2017-08-04       Impact factor: 3.449

4.  Induction of type 2 iodothyronine deiodinase in the mediobasal hypothalamus by bacterial lipopolysaccharide: role of corticosterone.

Authors:  Edith Sánchez; Praful S Singru; Csaba Fekete; Ronald M Lechan
Journal:  Endocrinology       Date:  2008-01-24       Impact factor: 4.736

Review 5.  Thyroid hormone and cerebellar development.

Authors:  Grant W Anderson
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

6.  Type 3 deiodinase, a thyroid-hormone-inactivating enzyme, controls survival and maturation of cone photoreceptors.

Authors:  Lily Ng; Arkady Lyubarsky; Sergei S Nikonov; Michelle Ma; Maya Srinivas; Benjamin Kefas; Donald L St Germain; Arturo Hernandez; Edward N Pugh; Douglas Forrest
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

7.  Type 3 iodothyronine deiodinase in neonatal goats: molecular cloning, expression, localization, and methylation signature.

Authors:  Tao Zhong; Peng-Fei Jin; Wei Zhao; Lin-Jie Wang; Li Li; Hong-Ping Zhang
Journal:  Funct Integr Genomics       Date:  2016-04-23       Impact factor: 3.410

8.  Adult onset of type 3 deiodinase deficiency in mice alters brain gene expression and increases locomotor activity.

Authors:  J Patrizia Stohn; M Elena Martinez; Donald L St Germain; Arturo Hernandez
Journal:  Psychoneuroendocrinology       Date:  2019-09-18       Impact factor: 4.905

9.  Decreased anxiety- and depression-like behaviors and hyperactivity in a type 3 deiodinase-deficient mouse showing brain thyrotoxicosis and peripheral hypothyroidism.

Authors:  J Patrizia Stohn; M Elena Martinez; Arturo Hernandez
Journal:  Psychoneuroendocrinology       Date:  2016-08-24       Impact factor: 4.905

10.  Cerebellar abnormalities in mice lacking type 3 deiodinase and partial reversal of phenotype by deletion of thyroid hormone receptor α1.

Authors:  Robin P Peeters; Arturo Hernandez; Lily Ng; Michelle Ma; David S Sharlin; Mritunjay Pandey; William F Simonds; Donald L St Germain; Douglas Forrest
Journal:  Endocrinology       Date:  2012-11-16       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.